- TWD61.90bn
- TWD60.20bn
- TWD57.00bn
- 90
- 56
- 69
- 86
Annual balance sheet for Topco Scientific Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4,761 | 5,141 | 5,592 | 6,917 | 5,483 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6,213 | 8,011 | 8,894 | 8,432 | 10,158 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 14,434 | 16,897 | 20,592 | 20,512 | 21,592 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,731 | 3,970 | 4,176 | 4,347 | 9,860 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 21,452 | 25,174 | 29,880 | 31,636 | 37,275 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9,442 | 11,510 | 14,149 | 12,727 | 14,954 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 10,878 | 13,578 | 16,921 | 16,526 | 19,504 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 10,574 | 11,597 | 12,960 | 15,109 | 17,771 |
| Total Liabilities & Shareholders' Equity | 21,452 | 25,174 | 29,880 | 31,636 | 37,275 |
| Total Common Shares Outstanding |